In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs

HOME

HELP

FEEDBACK

SUBSCRIPTIONS

Research Articles

In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs

B Pradines, C Rogier, T Fusai, A Tall, JF Trape, and JC Doury

The in vitro activity of artemether against 56 African isolates of Plasmodium falciparum from Senegal was evaluated using an isotope-based drug susceptibility semi-microtest. The 50% inhibitory concentration (IC50) values for artemether were in a narrow range from 0.8 to 15.2 nM (mean IC50 = 3.43 nM) and the 95% confidence interval (CI) was 2.50-4.36 nM. Artemether was equally effective on chloroquine-sensitive and chloroquine-resistant isolates (mean IC50 = 346 nM, 95% CI = 2.08-4.84 nM versus mean IC50 = 2.80 nM, 95% CI = 2.00-3.60 nM). There was a significant positive correlation between responses to artemether and mefloquine (r2 = 0.36, P < 0.001), artemether and quinine (r2 = 0.085, P < 0.05), artemether and halofantrine (r2 = 0.075, P < 0.05), quinine and mefloquine (r2 = 0.205, P < 0.01), quinine and halofantrine (r2 = 0.124, P < 0.05), and mefloquine and halofantrine (r2 = 0.801, P < 0.001). A positive correlation between these drugs suggests in vitro cross-resistance or at least in vitro cross-susceptibility.

This article has been cited by other articles:

R. Tahar, P. Ringwald, and L. K. Basco
Molecular Epidemiology of Malaria in Cameroon. XXVIII. In vitro Activity of Dihydroartemisinin against Clinical Isolates of Plasmodium falciparum and Sequence Analysis of the P. falciparum ATPase 6 Gene
Am J Trop Med Hyg, July 1, 2009; 81(1): 13 - 18.
[Abstract] [Full Text] [PDF]

E. Legrand, B. Volney, J.-B. Meynard, O. Mercereau-Puijalon, and P. Esterre
In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005
Antimicrob. Agents Chemother., January 1, 2008; 52(1): 288 - 298.
[Abstract] [Full Text] [PDF]

L. K. BASCO and P. RINGWALD
MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIV. TRENDS OF IN VITRO ANTIMALARIAL DRUG RESPONSES IN YAOUNDE, CAMEROON
Am J Trop Med Hyg, January 1, 2007; 76(1): 20 - 26.
[Abstract] [Full Text] [PDF]

B. Pradines, P. Hovette, T. Fusai, H. L. Atanda, E. Baret, P. Cheval, J. Mosnier, A. Callec, J. Cren, R. Amalvict, et al.
Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the Congo.
J. Clin. Microbiol., July 1, 2006; 44(7): 2404 - 2408.
[Abstract] [Full Text] [PDF]

M. HENRY, I. DIALLO, J. BORDES, S. KA, B. PRADINES, B. DIATTA, P. S. M'BAYE, M. SANE, M. THIAM, P. M. GUEYE, et al.
Urban malaria in dakar, senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Am J Trop Med Hyg, July 1, 2006; 75(1): 146 - 151.
[Abstract] [Full Text] [PDF]

S. T. Mariga, J. P. Gil, C. Sisowath, W. H. Wernsdorfer, and A. Bjorkman
Synergism between Amodiaquine and Its Major Metabolite, Desethylamodiaquine, against Plasmodium falciparum In Vitro
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4089 - 4096.
[Abstract] [Full Text] [PDF]

M. L. Ancelin, M. Calas, V. Vidal-Sailhan, S. Herbute, P. Ringwald, and H. J. Vial
Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2590 - 2597.
[Abstract] [Full Text] [PDF]

T. NGO, M. DURAISINGH, M. REED, D. HIPGRAVE, B. BIGGS, and A. F. COWMAN
ANALYSIS OF PFCRT, PFMDR1, DHFR, AND DHPS MUTATIONS AND DRUG SENSITIVITIES IN PLASMODIUM FALCIPARUM ISOLATES FROM PATIENTS IN VIETNAM BEFORE AND AFTER TREATMENT WITH ARTEMISININ
Am J Trop Med Hyg, March 1, 2003; 68(3): 350 - 356.
[Abstract] [Full Text] [PDF]

R. N. Price, C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna
The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparum from the Western Border of Thailand
Antimicrob. Agents Chemother., December 1, 1999; 43(12): 2943 - 2949.
[Abstract] [Full Text]

G. Di Perri, P. Olliaro, S. Ward, B. Allegranzi, S. Bonora, and E. Concia
Rapid absorption and clinical effectiveness of intragastric mefloquine in the treament of cerebral malaria in African children
J. Antimicrob. Chemother., October 1, 1999; 44(4): 573 - 576.
[Abstract] [Full Text] [PDF]

B. Pradines, A. Tall, T. Fusai, A. Spiegel, R. Hienne, C. Rogier, J. F. Trape, J. Le Bras, and D. Parzy
In Vitro Activities of Benflumetol against 158�Senegalese Isolates of Plasmodium falciparum in Comparison with Those of Standard Antimalarial Drugs
Antimicrob. Agents Chemother., February 1, 1999; 43(2): 418 - 420.
[Abstract] [Full Text]

				E. Legrand, B. Volney, J.-B. Meynard, O. Mercereau-Puijalon, and P. Esterre In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005 Antimicrob. Agents Chemother., January 1, 2008; 52(1): 288 - 298. [Abstract] [Full Text] [PDF]

				L. K. BASCO and P. RINGWALD MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIV. TRENDS OF IN VITRO ANTIMALARIAL DRUG RESPONSES IN YAOUNDE, CAMEROON Am J Trop Med Hyg, January 1, 2007; 76(1): 20 - 26. [Abstract] [Full Text] [PDF]

				B. Pradines, P. Hovette, T. Fusai, H. L. Atanda, E. Baret, P. Cheval, J. Mosnier, A. Callec, J. Cren, R. Amalvict, et al. Prevalence of In Vitro Resistance to Eleven Standard or New Antimalarial Drugs among Plasmodium falciparum Isolates from Pointe-Noire, Republic of the Congo. J. Clin. Microbiol., July 1, 2006; 44(7): 2404 - 2408. [Abstract] [Full Text] [PDF]

				M. HENRY, I. DIALLO, J. BORDES, S. KA, B. PRADINES, B. DIATTA, P. S. M'BAYE, M. SANE, M. THIAM, P. M. GUEYE, et al. Urban malaria in dakar, senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg, July 1, 2006; 75(1): 146 - 151. [Abstract] [Full Text] [PDF]

				S. T. Mariga, J. P. Gil, C. Sisowath, W. H. Wernsdorfer, and A. Bjorkman Synergism between Amodiaquine and Its Major Metabolite, Desethylamodiaquine, against Plasmodium falciparum In Vitro Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4089 - 4096. [Abstract] [Full Text] [PDF]

				M. L. Ancelin, M. Calas, V. Vidal-Sailhan, S. Herbute, P. Ringwald, and H. J. Vial Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial Activities Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2590 - 2597. [Abstract] [Full Text] [PDF]

				T. NGO, M. DURAISINGH, M. REED, D. HIPGRAVE, B. BIGGS, and A. F. COWMAN ANALYSIS OF PFCRT, PFMDR1, DHFR, AND DHPS MUTATIONS AND DRUG SENSITIVITIES IN PLASMODIUM FALCIPARUM ISOLATES FROM PATIENTS IN VIETNAM BEFORE AND AFTER TREATMENT WITH ARTEMISININ Am J Trop Med Hyg, March 1, 2003; 68(3): 350 - 356. [Abstract] [Full Text] [PDF]

				R. N. Price, C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparum from the Western Border of Thailand Antimicrob. Agents Chemother., December 1, 1999; 43(12): 2943 - 2949. [Abstract] [Full Text]

				G. Di Perri, P. Olliaro, S. Ward, B. Allegranzi, S. Bonora, and E. Concia Rapid absorption and clinical effectiveness of intragastric mefloquine in the treament of cerebral malaria in African children J. Antimicrob. Chemother., October 1, 1999; 44(4): 573 - 576. [Abstract] [Full Text] [PDF]

				B. Pradines, A. Tall, T. Fusai, A. Spiegel, R. Hienne, C. Rogier, J. F. Trape, J. Le Bras, and D. Parzy In Vitro Activities of Benflumetol against 158�Senegalese Isolates of Plasmodium falciparum in Comparison with Those of Standard Antimalarial Drugs Antimicrob. Agents Chemother., February 1, 1999; 43(2): 418 - 420. [Abstract] [Full Text]